Abstract: Thaxtomins are diketopiperazine phytotoxins produced by Streptomyces scabies and other actinobacterial plant pathogens that inhibit cellulose biosynthesis in plants.D ue to their potent bioactivity and novel mode of action there has been considerable interest in developing thaxtomins as herbicides for crop protection. To address the need for more stable derivatives,w eh ave developed an ew approach for structural diversification of thaxtomins.G enes encoding the thaxtomin NRPS from S. scabies,along with genes encoding apromiscuous tryptophan synthase (TrpS) from Salmonella typhimurium, were assembled in ah eterologous host Streptomyces albus.U pon feeding indole derivatives to the engineered S. albus strain, tryptophan intermediates with alternative substituents are biosynthesized and incorporated by the NRPS to deliver as eries of thaxtomins with different functionalities in place of the nitro group.T he approach described herein, demonstrates howgenes from different pathwaysand different bacterial origins can be combined in ah eterologous host to create ad en ovo biosynthetic pathwayt o" non-natural" product target compounds.
Many valuable therapeutic agents and agrochemicals are derived from natural products.H owever,m any of these compounds do not have the necessary bioactivity or physicochemical properties at the outset, and further derivatization or analogue synthesis is required to develop optimized, effective compounds.T his optimization is traditionally achieved through semi-synthesis or total synthesis.H owever, multistep chemical synthesis often requires deleterious reagents and can be costly,w hich is particularly problematic for the development of agrochemicals that need to be produced in large quantities.B iosynthetic engineering is an alternative approach to produce new and potentially improved natural product variants directly by fermentation. [1, 2] Although biosynthetic engineering has been used to generate novel "non-natural" products [1] [2] [3] [4] [5] [6] most approaches have been limited to manipulating biosynthetic pathways in the well characterized native producers.H owever there are many microorganisms that produce useful secondary metabolites,which are not amenable to such genetic manipulation. Ther ise of synthetic biology has provided access to larger synthetic DNAc onstructs,r apid DNAc apture, [7] [8] [9] editing, [10, 11] assembly, [12, 13] and other advances. [14, 15] Theprospect of using these new tools to assemble de novo biosynthetic pathways in well-characterized heterologous host strains [16, 17] for diversification and optimization of natural products, derived from less tractable microorganisms,i sa na ttractive goal.
In this paper we describe anew approach for the de novo biosynthesis of "non-natural" variants of thaxtomin phytotoxins produced by Streptomyces scabies ( Figure 1A) , which inhibit cellulose biosynthesis in plants. [18, 19] Thaxtomins (1-11)are biosynthesized from l-phenylalanine and the unusual l-4-nitrotryptophan, which is produced by TxtD and TxtE enzymes ( Figure 1B) . [20] [21] [22] [23] TxtD is an itric oxide (NO) synthase and TxtE, aP 450 enzyme,t hen utilizes this NO with O 2 ,t oc atalyze nitration at the 4-position of l-tryptophan. [21, 24] Nonribosomal peptide synthetases (NRPS) TxtA and TxtB activate the l-phenylalanine and l-4-nitrotryptophan precursors,c atalyzing subsequent condensation, Nmethylation and cyclisation to give diketopiperazines including thaxtomin D( 3). AP 450 monooxygenase,T xtC,t hen hydroxylates the l-phenylalanine residue at the a-position and at either 2-, 3-, or 4-positions of the aryl group resulting in afamily of compounds (4-11)with thaxtomin A(6)being the major metabolite produced by S. scabies. [25] [26] [27] [28] Thep otent herbicidal activity and novel mode of action has driven the development of several synthetic routes to thaxtomins. [29] [30] [31] [32] [33] [34] [35] [36] However,t hese routes are all multi-step,l ow yielding,a nd produce diastereoisomeric mixtures.W et herefore sought to establish an alternative biosynthetic route for the production of thaxtomin derivatives.P revious studies have established that the 4-nitro substituent of the l-tryptophan is important for bioactivity.H owever this moiety is photolabile and can result in harmful degradation products. [37, 38] Consequently, thaxtomin derivatives with alternative substituents at the C4 position of the indole ring were identified as target compounds for synthetic biology.
In addition to being difficult to genetically manipulate, S. scabies and other thaxtomin producers are plant pathogens with tight regulations controlling their use and genetic modification. It was thus desirable to establish heterologous expression of thaxtomin biosynthetic genes in am ore tractable strain. To this end, Streptomyces albus was selected as as uitable host. Initially at wo-step process for production of thaxtomin derivatives was envisaged;abiotransformation step utilizing tryptophan synthase (TrpS) to produce 4-substituted l-tryptophans (Figure 2 ), which are then fed to an S. albus strain possessing the NRPS TxtA and TxtB ( Figure 3 ). Previous studies have shown that the Tr pS from Salmonella typhimurium (ATCC 37845) is promiscuous and will condense arange of indole derivatives with l-serine or lthreonine to yield l-Trp derivatives. [39] [40] [41] [42] To explore if this enzyme could be used to generate alibrary of C4-substituted tryptophan analogues, StTrpS was overproduced in E. coli BL21 and the resulting cell lysate incubated with avariety of 4-substituted indoles.T he resulting tryptophan analogues were isolated with yields ranging from 5-49 %( Figure 2 ). For the second step in the process (Figure 3 ), NRPS-encoding genes txtA and txtB were amplified from S. scabies genomic DNAa st wo separate DNAp arts,w ith optimized ribosomal binding sites and spacer sequences replacing the native RBS and spacer sequences of each gene.T hese two DNAp arts were then assembled into an on-integrative vector under the control of the constitutive ermE* promoter. This vector was conjugated into S. albus and the resulting strain ( Figure 3 , i) was supplemented with l-4-nitrotryptophan (12) . After 3days of fermentation the cells were removed and the culture supernatant was purified by C18 RP-HPLC affording thaxtomin D( 3).
The S. albus::txtAB strain was then supplemented with the tryptophan derivatives 13-20 which resulted in new thaxtomin Danalogues possessing Cl, Br, F, or Me substituents at C4 of the indole moiety (23) (24) (25) (26) ( Figure 3 , Table S1 and Figure S1A in the Supporting Information). Interestingly,o ther than 4-nitrotryptophan, none of the tryptophan analogues possessing more polar substituents were incorporated. This could be due to substrate selectivity of the thaxtomin NRPS and/or less efficient cellular uptake of the more polar l-Trp derivatives.T oexplore if the structural diversity of thaxtomin derivatives could be further expanded, 4-chloro-and 4-bromo-7-azatryptophans (21 & 22) w ere prepared ( Figure 2 ) and fed to S. albus:txtAB. Whilst, 4-chloro-and 4-bromotryptophan (13 & 14) a re accepted, the corresponding azatryptophans (21 & 22) , which are the same size but more polar, are not incorporated which further suggests that hydrophobicity rather than steric factors appear to govern selectivity of the NRPS.I na ddition to the five thaxtomin D analogues,anew thaxtomin containing unmodified tryptophan (27) was also detected in each of the cultures,including those that were not supplemented with exogenous precursors. There is no evidence in the literature of desnitro thaxtomins being produced by S. scabies,a nd none were detected in cultures of S. scabies grown for this study.P resumably in the wild type S. scabies l-4-nitrotryptophan is present in abundance during thaxtomin production, which prevents TxtB loading l-tryptophan. Another strain, Streptomyces ipomoeae,i sreported to make desnitro thaxtomin(s), this strain may be less efficient in producing l-4-nitrotryptophan and/or may possess amore promiscuous NRPS assembly line. [43] While thaxtomin D( 3)i sk nown to possess some herbicidal activity,t he hydroxylated thaxtomin A( 6)i samore potent herbicide,mostly due to again in solubility rather than any direct increase in biological activity. [28] To this end athird DNAp art, with optimized ribosomal binding and spacer sequence,w as constructed by amplifying the thaxtomin hydroxylase txtC from S. scabies genomic DNA. All three DNAp arts (txtA, txtB and txtC)w ere then assembled together into as ynthetic operon, within the non-integrative vector, under the control of the ermE* promoter and introduced into the S. albus host. Ther esulting strain S. albus::txtABC (Figure 3 , ii)was cultivated and supplemented with 4-nitrotryptophan, which resulted in am ajor product with m/z 439.1616, which has an identical HPLC retention time and MS-MS to asample of thaxtomin A(6)(D 0.4 ppm), which was isolated from S. scabies (Table S2 , Figure S2 ). Tw o other minor products (< 10 %) were also evident with m/z 439.1623 and 439.1621 (D 1a nd 0.8 ppm), which are most likely regioisomers that have undergone hydroxylation at the a-position and at C2 or C4 of the l-phenylalanine aryl group. These additional two peaks are also present in samples of thaxtomin Ai solated from S. scabies with identical retention times and MS fragmentation patterns ( Figure S2 ). It has previously been shown that whilst thaxtomin Ai st he main metabolite produced by S. scabies minor congeners that have undergone hydroxylation at C2 or C4 (5 & 7, Figure 1A) can also be isolated. [44] Taken together with the results presented here,this suggest that the P450 hydroxylase TxtC has relaxed regioselectivity.I na ddition, S. albus:txtABC supplemented with 4-nitrotryptophan also produced minor amounts of am etabolite with m/z 407.1710, which was identical to thaxtomin D( 3)(D 0.3 ppm), and ametabolite m/z 423.1667, consistent with the mono-hydroxylated derivative 4 (D 0.4 ppm) ( Figure S3 ). It has previously been postulated that TxtC first hydroxylates the a-carbon of the phenylalanine, before introducing as econd hydroxyl group on the aromatic ring as only thaxtomins singly hydroxylated at the a position have been isolated from the wild type strain (compound 4 and 9,F igure 1A). [44] Having established that S. albus::txtABC (Figure 3 , ii)can produce hydroxylated thaxtomin A, this strain was then supplemented with tryptophan derivatives 13-16.T his resulted in new hydroxylated thaxtomin analogues with either Cl, Br,F ,o rM eg roup at the 4-position of the indole ring. As with the natural pathway,t he cultures fed with the three halogenated tryptophan analogues (13-15)also resulted in several dihydroxylated thaxtomins variants,w ith as ingle regioisomer forming preferentially (> 75 %, Figure S4 i-iv, Table S2 ). Some residual non hydroxylated and singly hydroxylated intermediates could also be detected in each case.Methylated and desnitro thaxtomins (compounds 26 and 27)were also converted by TxtC into hydroxylated analogues, however these two substrates resulted in the formation of as ingly hydroxylated compound predominantly with around 25 %c onversion to the major doubly hydroxylated product ( Figure S4 v,vi) .
It was then envisaged that at hird strain could be developed that was capable of producing thaxtomin analogues directly from simple,c ommercially available indole starting materials by introducing the tryptophan synthase genes, trpA and trpB,from S. typhimurium,a long with genes encoding the thaxtomin NRPS, txtA and txtB,into the S. albus host (Figure 4 ). Using 4-substituted indole as the starting material would also provide more lipophilic substrates that may promote better cellular uptake than the more polar tryptophan precursors.T he trpA and trpB genes from S. typhimurium were optimized for codon usage in Streptomyces and used to create two further DNAp arts with ribosome binding and spacer sequences optimized which were then assembled together with the S. scabies txtA and txtB into the non-integrative ermE*p containing vector used before and conjugated into the S. albus host. Cultures of this exconjugant (S. albus::txtAB,trpAB,F igure 4) were supplemented with commercially available indole analogues.F ollowing several days incubation, thaxtomin D( 3)a nd analogues possessing Br,C l, F, and Me substituents (23-26)w ere again produced. In contrast, control experiments,where indole analogues are fed to S. albus::txtAB or S. albus::txtABC strains lacking the heterologous trpAB, produced only trace amounts of thaxtomin analogues ( Figure S6 and S7), which illustrates the success of this de novo pathway ( Figure S5 ). Thef act that S. albus::txtAB,trpAB failed to produce thaxtomin derivatives from the indoles with polar substituents,despite the increased lipophilicity of the indole versus tryptophan, indicates that cellular uptake may not be the reason why these are not accepted as substrates by the pathway,i nstead A-domain specificity may be limiting analogue incorporation. In summary,wehave assembled anovel artificial pathway that allows thaxtomin analogues to be generated in vivo in as ingle fermentation step from indole precursors.T rpS has been widely used to generate tryptophan analogues in vitro, however the work described here shows how Tr pS can also be exploited to generate tryptophan derivatives in vivo providing alternative precursors for incorporation into natural products.Given that there are many natural products derived from tryptophan, this approach could be adopted to create aw ide range of new biosynthetic assembly lines,i nvivo, generating novel natural product variants.C onsequently,i n addition to providing new ways of producing more effective herbicides,t his approach could also be applied to diversify aw ide range of other bioactive natural product scaffolds including important antibiotics.O ne can envisage expanding this concept, of combining multiple enzymes from different pathways and origins in heterologous host strains,t oc reate many novel "non-natural" variants for agrochemical, therapeutic and other applications.
